How to Donate
What is Fragile X?
About FRAXA
Research
Newsroom
Events
Videos
Shop
Contact Us
Next Fundraisers
- Golf Tourney, NH, 5/25/12
- Patrick's Pals, MA, 6/2/12
- Cruise-In, PA 6/3/12
How to Donate
You can help us find a cure
for Fragile X!
What is Fragile X?
Fragile X is the most common inherited cause of mental impairment and the most common known cause of autism.
About FRAXA
FRAXA is a 501c3 nonprofit run by parents. Our mission: to find treatments and a cure for Fragile X. FRAXA has funded over $20 million in research.
Clinical Trials Happening
Now - Volunteers Needed
Email Signup
Get the latest FRAXA News!
April 16, 2012
Clinical trials of three experimental new treatments for Fragile X are accepting participants
slides from today's FRAXA Webinar
There are active trials with two different mGluR5 antagonists - one from Novartis, the other from Roche - and arbaclofen from Seaside Therapeutics - in large scale trials.
read more >
April 11, 2012
Fragile X syndrome reversed in adult mice
A new study used used a compound that inhibits mGluR5 to correct signs of Fragile X. The work was done by a team led by Dr. Lothar Lindemann at Roche, and a group led by Dr. Mark Bear at MIT.
read more >
April 03, 2012
FRAXA Announces 2012 Fragile X Research Awards
$1,132,923 in New Program Grants, Postdoctoral Fellowships, and Renewals have been approved. We are funding over $846,000 in new projects; renewals total $285,678 and will increase as additional projects reach their one year mark.
read more >
March 21, 2012
Knockout Rat Model for Fragile X: shipping 4/2/12
Genetically engineered Fragile X Knockout mice will give scientists a new key to understanding Fragile X.
read more >